Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publicación Artículo científico (JournalArticle)

Identification of cancer related genes using a comprehensive map of human gene expression

  • Torrente Orihuela, Ester Aurora
  • Lukk, Margus
  • Xue, Vincent
  • Parkinson, Helen
  • Rung, Johan
  • Brazma, Alvis
Rapid accumulation and availability of gene expression datasets in public repositories have enabled large-scale meta-analyses of combined data. The richness of cross-experiment data has provided new biological insights, including identification of new cancer genes. In this study, we compiled a human gene expression dataset from similar to 40,000 publicly available Affymetrix HG-U133Plus2 arrays. After strict quality control and data normalisation the data was quantified in an expression matrix of similar to 20,000 genes and similar to 28,000 samples. To enable different ways of sample grouping, existing annotations where subjected to systematic ontology assisted categorisation and manual curation. Groups like normal tissues, neoplasmic tissues, cell lines, homoeotic cells and incompletely differentiated cells were created. Unsupervised analysis of the data confirmed global structure of expression consistent with earlier analysis but with more details revealed due to increased resolution. A suitable mixed-effects linear model was used to further investigate gene expression in solid tissue tumours, and to compare these with the respective healthy solid tissues. The analysis identified 1,285 genes with systematic expression change in cancer. The list is significantly enriched with known cancer genes from large, public, peer-reviewed databases, whereas the remaining ones are proposed as new cancer gene candidates. The compiled dataset is publicly available in the ArrayExpress Archive. It contains the most diverse collection of biological samples, making it the largest systematically annotated gene expression dataset of its kind in the public domain., AB received funding from the EurocanPlatform grant of FP7 frameworks from the European Commission. AT was partially supported by the Ramón Areces Foundation.
Repisalud
Publicación Artículo científico (JournalArticle)

c-RAF Ablation Induces Regression of Advanced Kras/Trp53 Mutant Lung Adenocarcinomas by a Mechanism Independent of MAPK Signaling.

  • Sanclemente, Manuel
  • Francoz, Sarah
  • Esteban-Burgos, Laura
  • Bousquet-Mur, Emilie
  • Djurec, Magdolna
  • Lopez-Casas, Pedro P
  • Hidalgo, Manuel
  • Guerra, Carmen
  • Barbacid, Mariano
  • Musteanu, Mónica
  • Drosten, Matthias
A quarter of all solid tumors harbor KRAS oncogenes. Yet, no selective drugs have been approved to treat these malignancies. Genetic interrogation of the MAPK pathway revealed that systemic ablation of MEK or ERK kinases in adult mice prevent tumor development but are unacceptably toxic. Here, we demonstrate that ablation of c-RAF expression in advanced tumors driven by KrasG12V/Trp53 mutations leads to significant tumor regression with no detectable appearance of resistance mechanisms. Tumor regression results from massive apoptosis. Importantly, systemic abrogation of c-RAF expression does not inhibit canonical MAPK signaling, hence, resulting in limited toxicities. These results are of significant relevance for the design of therapeutic strategies to treat K-RAS mutant cancers.
Repisalud
Publicación Artículo científico (JournalArticle)

A Braf kinase-inactive mutant induces lung adenocarcinoma.

  • Nieto, Patricia
  • Ambrogio, Chiara
  • Esteban-Burgos, Laura
  • Gómez-López, Gonzalo
  • Blasco, María Teresa
  • Yao, Zhan
  • Marais, Richard
  • Rosen, Neal
  • Chiarle, Roberto
  • Pisano, David G
  • Barbacid, Mariano
  • Santamaría, David
  • Nieto, Patricia
  • Ambrogio, Chiara
  • Esteban-Burgos, Laura
  • Gómez-López, Gonzalo
  • Blasco, María Teresa
  • Yao, Zhan
  • Marais, Richard
  • Rosen, Neal
  • Chiarle, Roberto
  • Pisano, David G
  • Santamaría, David
The initiating oncogenic event in almost half of human lung adenocarcinomas is still unknown, a fact that complicates the development of selective targeted therapies. Yet these tumours harbour a number of alterations without obvious oncogenic function including BRAF-inactivating mutations. Inactivating BRAF mutants in lung predominate over the activating V600E mutant that is frequently observed in other tumour types. Here we demonstrate that the expression of an endogenous Braf(D631A) kinase-inactive isoform in mice (corresponding to the human BRAF(D594A) mutation) triggers lung adenocarcinoma in vivo, indicating that BRAF-inactivating mutations are initiating events in lung oncogenesis. Moreover, inactivating BRAF mutations have also been identified in a subset of KRAS-driven human lung tumours. Co-expression of Kras(G12V) and Braf(D631A) in mouse lung cells markedly enhances tumour initiation, a phenomenon mediated by Craf kinase activity, and effectively accelerates tumour progression when activated in advanced lung adenocarcinomas. We also report a key role for the wild-type Braf kinase in sustaining Kras(G12V)/Braf(D631A)-driven tumours. Ablation of the wild-type Braf allele prevents the development of lung adenocarcinoma by inducing a further increase in MAPK signalling that results in oncogenic toxicity; this effect can be abolished by pharmacological inhibition of Mek to restore tumour growth. However, the loss of wild-type Braf also induces transdifferentiation of club cells, which leads to the rapid development of lethal intrabronchiolar lesions. These observations indicate that the signal intensity of the MAPK pathway is a critical determinant not only in tumour development, but also in dictating the nature of the cancer-initiating cell and ultimately the resulting tumour phenotype.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Association of leukocyte DNA methylation changes with dietary folate and alcohol intake in the EPIC study

  • Perrier, Flavie
  • Viallon, V.
  • Ambatipudi, S.
  • Ghantous, A.
  • Cuenin, C.
  • Hernandez Vargas, H.
  • Chajès, Véronique
  • Baglietto, Laura
  • Matejcic, Marco
  • Moreno Macias, H.
  • Kühn, Tilman
  • Boeing, Heiner
  • Karakatsani, A.
  • Kotanidou, A.
  • Trichopoulou, Antonia
  • Sieri, S
  • Panico, Salvatore
  • Fasanelli, F.
  • Dolle, M.
  • Onland-Moret, N. Charlotte
  • Sluijs, I.
  • Weiderpass, Elisabete
  • Quirós, José Ramón
  • Agudo, Antonio
  • Huerta Castaño, José María
  • Ardanaz, Eva
  • Dorronsoro, Miren
  • Tong, T. Y. N.
  • Tsilidis, Konstantinos K.
  • Riboli, Elio
  • Gunter, Marc J.
  • Herceg, Z.
  • Ferrari, Pietro
  • Romieu, I.
Background: There is increasing evidence that folate, an important component of one-carbon metabolism, modulates the epigenome. Alcohol, which can disrupt folate absorption, is also known to affect the epigenome. We investigated the association of dietary folate and alcohol intake on leukocyte DNA methylation levels in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Leukocyte genome-wide DNA methylation profiles on approximately 450,000 CpG sites were acquired with Illumina HumanMethylation 450K BeadChip measured among 450 women control participants of a case-control study on breast cancer nested within the EPIC cohort. After data preprocessing using surrogate variable analysis to reduce systematic variation, associations of DNA methylation with dietary folate and alcohol intake, assessed with dietary questionnaires, were investigated using CpG site-specific linear models. Specific regions of the methylome were explored using differentially methylated region (DMR) analysis and fused lasso (FL) regressions. The DMR analysis combined results from the feature-specific analysis for a specific chromosome and using distances between features as weights whereas FL regression combined two penalties to encourage sparsity of single features and the difference between two consecutive features. Results: After correction for multiple testing, intake of dietary folate was not associated with methylation level at any DNA methylation site, while weak associations were observed between alcohol intake and methylation level at CpG sites cg03199996 and cg07382687, with q(val)=0.029 and q(val)=0.048, respectively. Interestingly, the DMR analysis revealed a total of 24 and 90 regions associated with dietary folate and alcohol, respectively. For alcohol intake, 6 of the 15 most significant DMRs were identified through FL. Conclusions: Alcohol intake was associated with methylation levels at two CpG sites. Evidence from DMR and FL analyses indicated that dietary folate and alcohol intake may be associated with genomic regions with tumor suppressor activity such as the GSDMD and HOXA5 genes. These results were in line with the hypothesis that epigenetic mechanisms play a role in the association between folate and alcohol, although further studies are warranted to clarify the importance of these mechanisms in cancer.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Interrogating open issues in cancer precision medicine with patient-derived xenografts

  • Byrne, Annette T.
  • Alférez, Denis G.
  • Amant, Frédéric
  • Annibali, Daniela
  • Arribas, Joaquín V. (Vicente)
  • Biankin, Andrew V.
  • Bruna, Alejandra
  • Budinská, Eva
  • Caldas, Carlos
  • Chang, David K.
  • Clarke, Robert B.
  • Clevers, Hans
  • Coukos, George
  • Dangles Marie, Virginie
  • Eckhardt, S. Gail
  • González Suárez, Eva
  • Hermans, Els
  • Hidalgo, Manuel
  • Jarzabek, Monika A.
  • Jong, Steven de
  • Jonkers, Jos
  • Kemper, Kristel
  • Lanfrancone, Luisa
  • Mælandsmo, Gunhild Mari
  • Marangoni, Elisabetta
  • Marine, Jean-Christophe
  • Medico, Enzo
  • Norum, Jens Henrik
  • Palmer, Héctor G.
  • Peeper, Daniel S.
  • Pelicci, Pier Giuseppe
  • Piris Gimenez, Alejandro
  • Roman Roman, Sergio
  • Rueda, Oscar M.
  • Seoane Suárez, Joan
  • Serra Elizalde, Violeta
  • Soucek, Laura
  • Vanhecke, Dominique
  • Villanueva Garatachea, Alberto
  • Vinolo, Emilie
  • Bertotti, Andrea
  • Trusolino, Livio
Patient-derived xenografts (PDXs) have emerged as an important platform to elucidate new treatments and biomarkers in oncology. PDX models are used to address clinically relevant questions, including the contribution of tumour heterogeneity to therapeutic responsiveness, the patterns of cancer evolutionary dynamics during tumour progression and under drug pressure, and the mechanisms of resistance to treatment. The ability of PDX models to predict clinical outcomes is being improved through mouse humanization strategies and the implementation of co-clinical trials, within which patients and PDXs reciprocally inform therapeutic decisions. This Opinion article discusses aspects of PDX modelling that are relevant to these questions and highlights the merits of shared PDX resources to advance cancer medicine from the perspective of EurOPDX, an international initiative devoted to PDX-based research.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genetic characterization of the role of the Cip/Kip family of proteins as cyclin-dependent kinase inhibitors and assembly factors

  • Cerqueira, Antonio
  • Martín, Alberto
  • Barbacid, Mariano
  • Santamaría, David
et al., The Cip/Kip family, namely, p21Cip1, p27Kip1, and p57Kip2, are stoichiometric cyclin-dependent kinase inhibitors (CKIs). Paradoxically, they have been proposed to also act as positive regulators of Cdk4/6-cyclin D by stabilizing these heterodimers. Loss of p21Cip1 and p27Kip1 reduces Cdk4/6-cyclin D complexes, although with limited phenotypic consequences compared to the embryonic lethality of Cdk4/6 or triple cyclin D deficiency. This milder phenotype was attributed to Cdk2 compensatory mechanisms. To address this controversy using a genetic approach, we generated Cdk2-/- p21-/- p27-/- mice. Triple-knockout mouse embryonic fibroblasts (MEFs) displayed minimal levels of D-type cyclins and Cdk4/6-cyclin D complexes. p57Kip2 downregulation in the absence of p21Cip1 and p27Kip1 aggravated this phenotype, yet MEFs lacking all Cip/Kip proteins exhibited increased retinoblastoma phosphorylation, together with enhanced proliferation and transformation capacity. In vivo, Cdk2 ablation induced partial perinatal lethality in p21-/- p27-/- mice, suggesting partial Cdk2-dependent compensation. However, Cdk2-/- p21-/- p27-/- survivors displayed all phenotypes described for p27-/- mice, including organomegalia and pituitary tumors. Thus, Cip/Kip deficiency does not impair interphasic Cdk activity even in the absence of Cdk2, suggesting that their Cdk-cyclin assembly function is dispensable for homeostatic control in most cell types., This work was supported by grants from the European Research Council (ERC-AG/250297-RAS AHEAD), EU-Framework Programme (LSHG-CT-2007-037665/CHEMORES, HEALTH-F2-2010-259770/LUNGTARGET, and HEALTH-2010-260791/EUROCANPLAT-FORM), Spanish Ministry of Economy and Competitiveness (SAF2011-30173), and Autonomous Community of Madrid (S2011/BDM-2470/ONCOCYCLE) to M.B. C.E.S. is supported by a grant from the La Caixa/CNIO International Ph.D. Fellowship Program sponsored by the La Caixa Foundation (Spain)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma

  • Mainardi, Sara
  • Mijimolle, Nieves
  • Francoz, Sarah
  • Vicente-Dueñas, Carolina
  • Sánchez García, Isidro
  • Barbacid, Mariano
Ubiquitous expression of a resident K-RasG12V oncogene in adult mice revealed that most tissues are resistant to K-Ras oncogenic signals. Indeed, K-RasG12V expression only induced overt tumors in lungs. To identify these transformation-permissive cells, we induced K-RasG12V expression in a very limited number of adult lung cells (0.2%) and monitored their fate by X-Gal staining, a surrogate marker coexpressed with the K-Ras G12V oncoprotein. Four weeks later, 30% of these cells had proliferated to form small clusters. However, only SPC+ alveolar type II (ATII) cells were able to form hyperplastic lesions, some of which progressed to adenomas and adenocarcinomas. In contrast, induction of K-Ras G12V expression in lung cells by intratracheal infection with adenoviral-Cre particles generated hyperplasias in all regions except the proximal airways. Bronchiolar and bronchioalveolar duct junction hyperplasias were primarily made of CC10+ Clara cells. Some of them progressed to form benign adenomas. However, only alveolar hyperplasias, exclusively made up of SPC+ ATII cells, progressed to yield malignant adenocarcinomas. Adenoviral infection induced inflammatory infiltrates primarily made of T and B cells. This inflammatory response was essential for the development of K-RasG12V-driven bronchiolar hyperplasias and adenomas, but not for the generation of SPC+ ATII lesions. Finally, activation of K-RasG12V during embryonic development under the control of a Sca1 promoter yielded CC10+, but not SPC+, hyperplasias, and adenomas. These results, taken together, illustrate that different types of lung cells can generate benign lesions in response to K-Ras oncogenic signals. However, in adult mice, only SPC+ ATII cells were able to yield malignant adenocarcinomas., Work was supported by European Research Council Grant ERC-AG/250297-RAS AHEAD; EU-Framework Programme Grants LSHG-CT-2007-037665/CHEMORES, HEALTH-F2-2010-259770/LUNGTARGET, and HEALTH-010-260791/EUROCANPLATFORM; Spanish Ministry of Economy and Competitiveness Grant SAF2011-30173; Autonomous Community of Madrid S2011/BDM-2470/ONCOCYCLE (to M.B.); National Institutes of Health Grant R01 CA109335-04A1; Spanish Ministry of Economy and Competitivenes Grant SAF2012-32810; and EU-Framework Programme Grant FP7-ENV-2011/ARIMMORA (to I.S.-G.). S.M. was supported by a predoctoral fellowship from Fundación La Caixa., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Antibiotics as selectors and accelerators of diversity in the mechanisms of resistance: from the resistome to genetic plasticity in the β-lactamases world

  • Galán, Juan Carlos
  • González-Candelas, Fernando
  • Rolain, Jean Marc
  • Cantón, Rafael
Antibiotics and antibiotic resistance determinants, natural molecules closely related to bacterial physiology and consistent with an ancient origin, are not only present in antibiotic-producing bacteria. Throughput sequencing technologies have revealed an unexpected reservoir of antibiotic resistance in the environment. These data suggest that co-evolution between antibiotic and antibiotic resistance genes has occurred since the beginning of time. This evolutionary race has probably been slow because of highly regulated processes and low antibiotic concentrations. Therefore to understand this global problem, a new variable must be introduced, that the antibiotic resistance is a natural event, inherent to life. However, the industrial production of natural and synthetic antibiotics has dramatically accelerated this race, selecting some of the many resistance genes present in nature and contributing to their diversification. One of the best models available to understand the biological impact of selection and diversification are β-lactamases. They constitute the most widespread mechanism of resistance, at least among pathogenic bacteria, with more than 1000 enzymes identified in the literature. In the last years, there has been growing concern about the description, spread, and diversification of β-lactamases with carbapenemase activity and AmpC-type in plasmids. Phylogenies of these enzymes help the understanding of the evolutionary forces driving their selection. Moreover, understanding the adaptive potential of β-lactamases contribute to exploration the evolutionary antagonists trajectories through the design of more efficient synthetic molecules. In this review, we attempt to analyze the antibiotic resistance problem from intrinsic and environmental resistomes to the adaptive potential of resistance genes and the driving forces involved in their diversification, in order to provide a global perspective of the resistance problem., Juan-Carlos Galán was supported by research grants from Ministerio de Sanidad y Consumo (Instituto de Salud Carlos III, FIS-PI-12/00567) and HEALTH-F3-2011-282004 (EVOTAR) and HEALTH-F3-2010-241476 (PAR) from European Commission. Fernando González was supported by project BFU2011-24112 from MINECO (Spanish Government). Rafael Cantón was supported by national grant (PS09/00825) and LSHMCT-2008-223031 and FP7-HEALTH-2010-28251 from the European Union. Juan-Carlos Galán and Fernando González-Candelas belong to CIBERESP, Network for Biomedical Research in Epidemiology and Public Health (CB06/02/0053). Rafael Cantón also belongs to REIPI, Spanish Network for Research in Infectious Diseases (RD12/0015)., Peer reviewed, Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

H-Ras and K-Ras oncoproteins induce different tumor spectra when driven by the same regulatory sequences

  • Drosten, Matthias
  • Simón-Carrasco, Lucía
  • Hernández-Porras, Isabel
  • Lechuga, Carmen G.
  • Blasco, María T.
  • Jacob, Harrys K.C.
  • Fabbiano, Salvatore
  • Potenza, Nicoletta
  • Bustelo, Xosé R.
  • Guerra, Carmen
  • Barbacid, Mariano
Genetic studies in mice have provided evidence that H-Ras and K-Ras proteins are bioequivalent. However, human tumors display marked differences in the association of RAS oncogenes with tumor type. Thus, to further assess the bioequivalence of oncogenic H-Ras and K-Ras, we replaced the coding region of the murine K-Ras locus with H-Ras oncogene sequences. Germline expression of H-Ras or K-Ras from the K-Ras locus resulted in embryonic lethality. However, expression of these genes in adult mice led to different tumor phenotypes. Whereas H-Ras elicited papillomas and hematopoietictumors, K-Ras induced lung tumors and gastric lesions. Pulmonary expression of H-Ras created a senescence-like state caused by excessive MAPK signaling. Likewise, H-Ras but not K-Ras induced senescence in mouse embryonic fibroblasts. Label-free quantitative analysis revealed that minor differences in H-Ras expression levels led to drastically different biological outputs, suggesting that subtle differences in MAPK signaling confer nonequivalent functions that influence tumor spectra induced by RAS oncoproteins., This work was supported by grants from the European Research Council (ERC-AG/ 250297-RAS AHEAD), EU-Framework Programme (LSHG-CT-2007-037665/CHEMORES, HEALTH-F2-2010-259770/LUNGTARGET and HEALTH2010-260791/EUROCANPLATFORM), Spanish Ministry of Economy and Competitiveness (SAF2011-30173 and SAF2014-59864-R) and Autonomous Community of Madrid (S2011/BDM-2470/ONCOCYCLE) to MB, Castilla-León Autonomous Government (CSI101U13, BIO/SA01/15), the Spanish Ministry of Economy and Competitiveness (SAF2012-31371, RD12/0036/0002), Worldwide Cancer Research (14-1248), the Solórzano Foundation, and the Ramón Areces Foundation to XRB. Spanish government-sponsored funding to XRB is partially supported by the European Regional Development Fund. MB is the recipient of an Endowed Chair from the AXA Research Fund., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Inactivation of capicua in adult mice causes T-cell lymphoblastic lymphoma

  • Simón-Carrasco, Lucía
  • Graña-Castro, Osvaldo
  • Salmón, Marina
  • Jacob, Harrys K.C.
  • Gutiérrez, Alejandro
  • Jiménez, Gerardo
  • Drosten, Matthias
  • Barbacid, Mariano
CIC (also known as Capicua) is a transcriptional repressor negatively regulated by RAS/MAPK signaling. Whereas the functions of Cic have been well characterized in Drosophila, little is known about its role in mammals. CIC is inactivated in a variety of human tumors and has been implicated recently in the promotion of lung metastases. Here, we describe a mouse model in which we inactivated Cic by selectively disabling its DNA-binding activity, a mutation that causes derepression of its target genes. Germline Cic inactivation causes perinatal lethality due to lung differentiation defects. However, its systemic inactivation in adult mice induces T-cell acute lymphoblastic lymphoma (T-ALL), a tumor type known to carry CIC mutations, albeit with low incidence. Cic inactivation in mice induces T-ALL by a mechanism involving derepression of its well-known target, Etv4. Importantly, human T-ALL also relies on ETV4 expression for maintaining its oncogenic phenotype. Moreover, Cic inactivation renders T-ALL insensitive to MEK inhibitors in both mouse and human cell lines. Finally, we show that Ras-induced mouse T-ALL as well as human T-ALL carrying mutations in the RAS/MAPK pathway display a genetic signature indicative of Cic inactivation. These observations illustrate that CIC inactivation plays a key role in this human malignancy, This work was supported by grants from the Fundació La Marató de TV3 (20131730/1) to G.J. and M.B., and the European Research Council (ERC-AG/ 250297-RAS AHEAD), the EU-Framework Programme (HEALTH-F2-2010-259770/LUNGTARGET and HEALTH-2010- 260791/EUROCANPLATFORM), the Spanish Ministry of Economy and Competitiveness (SAF2014-59864-R), the Autonomous Community of Madrid (S2011/BDM-2470/ONCOCYCLE), and the Asociación Española contra el Cáncer (AECC) (GC16173694BARB) to M.B. M.B. is the recipient of an Endowed Chair from the AXA Research Fund. L.S.-C. was supported by a fellowship from the Programa de Formación de Personal Investigator (FPI) of the Spanish Ministry of Economy and Competitiveness., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A new mode of DNA binding distinguishes Capicua from other HMG-box factors and explains its mutation patterns in cancer

  • Forés, Marta
  • Simón-Carrasco, Lucía
  • Ajuria, Leiore
  • Samper, Núria
  • González-Crespo, Sergio
  • Drosten, Matthias
  • Barbacid, Mariano
  • Jiménez, Gerardo
HMG-box proteins, including Sox/SRY (Sox) and TCF/LEF1 (TCF) family members, bind DNA via their HMG-box. This binding, however, is relatively weak and both Sox and TCF factors employ distinct mechanisms for enhancing their affinity and specificity for DNA. Here we report that Capicua (CIC), an HMG-box transcriptional repressor involved in Ras/MAPK signaling and cancer progression, employs an additional distinct mode of DNA binding that enables selective recognition of its targets. We find that, contrary to previous assumptions, the HMG-box of CIC does not bind DNA alone but instead requires a distant motif (referred to as C1) present at the C-terminus of all CIC proteins. The HMG-box and C1 domains are both necessary for binding specific TGAATGAA-like sites, do not function via dimerization, and are active in the absence of cofactors, suggesting that they form a bipartite structure for sequence-specific binding to DNA. We demonstrate that this binding mechanism operates throughout Drosophila development and in human cells, ensuring specific regulation of multiple CIC targets. It thus appears that HMG-box proteins generally depend on auxiliary DNA binding mechanisms for regulating their appropriate genomic targets, but that each sub-family has evolved unique strategies for this purpose. Finally, the key role of C1 in DNA binding also explains the fact that this domain is a hotspot for inactivating mutations in oligodendroglioma and other tumors, while being preserved in oncogenic CIC-DUX4 fusion chimeras associated to Ewing-like sarcomas, This work was funded by grants from the Spanish Ministry of Economy and Competitiveness (MINECO) (BFU2011-23611 and BFU2014-52863-P) to GJ; the European Research Council (ERC-AG/ 250297-RAS AHEAD), the EU-Framework Programme (LSHG-CT-2007-037665/CHEMORES, HEALTH-F2-2010-259770/LUNGTARGET and HEALTH-2010-260791/EUROCANPLATFORM), the MINECO (SAF2011-30173 and SAF2014-59864-R), the Autonomous Community of Madrid (S2011/BDM-2470/ONCOCYCLE) to MB; and the Fundació La Marató de TV3 (20131730/1). LSC was supported by a fellowship from the Programa de Formación de Personal Investigador (FPI, MINECO). MB is a recipient of an Endowed Chair from the AXA Research Fund. GJ is an ICREA investigator., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Association of leukocyte DNA methylation changes with dietary folate and alcohol intake in the EPIC study

  • Perrier, Flavie
  • Viallon, V.
  • Ambatipudi, S.
  • Ghantous, A.
  • Cuenin, C.
  • Hernandez Vargas, H.
  • Chajès, Véronique
  • Baglietto, Laura
  • Matejcic, Marco
  • Moreno Macias, H.
  • Kühn, Tilman
  • Boeing, Heiner
  • Karakatsani, A.
  • Kotanidou, A.
  • Trichopoulou, Antonia
  • Sieri, S
  • Panico, Salvatore
  • Fasanelli, F.
  • Dolle, M.
  • Onland-Moret, N. Charlotte
  • Sluijs, I.
  • Weiderpass, Elisabete
  • Quirós, José Ramón
  • Agudo, Antonio
  • Huerta Castaño, José María
  • Ardanaz, Eva
  • Dorronsoro, Miren
  • Tong, T. Y. N.
  • Tsilidis, Konstantinos K.
  • Riboli, Elio
  • Gunter, Marc J.
  • Herceg, Z.
  • Ferrari, Pietro
  • Romieu, I.
Background: There is increasing evidence that folate, an important component of one-carbon metabolism, modulates the epigenome. Alcohol, which can disrupt folate absorption, is also known to affect the epigenome. We investigated the association of dietary folate and alcohol intake on leukocyte DNA methylation levels in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Leukocyte genome-wide DNA methylation profiles on approximately 450,000 CpG sites were acquired with Illumina HumanMethylation 450K BeadChip measured among 450 women control participants of a case-control study on breast cancer nested within the EPIC cohort. After data preprocessing using surrogate variable analysis to reduce systematic variation, associations of DNA methylation with dietary folate and alcohol intake, assessed with dietary questionnaires, were investigated using CpG site-specific linear models. Specific regions of the methylome were explored using differentially methylated region (DMR) analysis and fused lasso (FL) regressions. The DMR analysis combined results from the feature-specific analysis for a specific chromosome and using distances between features as weights whereas FL regression combined two penalties to encourage sparsity of single features and the difference between two consecutive features. Results: After correction for multiple testing, intake of dietary folate was not associated with methylation level at any DNA methylation site, while weak associations were observed between alcohol intake and methylation level at CpG sites cg03199996 and cg07382687, with q(val)=0.029 and q(val)=0.048, respectively. Interestingly, the DMR analysis revealed a total of 24 and 90 regions associated with dietary folate and alcohol, respectively. For alcohol intake, 6 of the 15 most significant DMRs were identified through FL. Conclusions: Alcohol intake was associated with methylation levels at two CpG sites. Evidence from DMR and FL analyses indicated that dietary folate and alcohol intake may be associated with genomic regions with tumor suppressor activity such as the GSDMD and HOXA5 genes. These results were in line with the hypothesis that epigenetic mechanisms play a role in the association between folate and alcohol, although further studies are warranted to clarify the importance of these mechanisms in cancer.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Interrogating open issues in cancer precision medicine with patient-derived xenografts

  • Byrne, Annette T.
  • Alférez, Denis G.
  • Amant, Frédéric
  • Annibali, Daniela
  • Arribas, Joaquín V. (Vicente)
  • Biankin, Andrew V.
  • Bruna, Alejandra
  • Budinská, Eva
  • Caldas, Carlos
  • Chang, David K.
  • Clarke, Robert B.
  • Clevers, Hans
  • Coukos, George
  • Dangles Marie, Virginie
  • Eckhardt, S. Gail
  • González Suárez, Eva
  • Hermans, Els
  • Hidalgo, Manuel
  • Jarzabek, Monika A.
  • Jong, Steven de
  • Jonkers, Jos
  • Kemper, Kristel
  • Lanfrancone, Luisa
  • Mælandsmo, Gunhild Mari
  • Marangoni, Elisabetta
  • Marine, Jean-Christophe
  • Medico, Enzo
  • Norum, Jens Henrik
  • Palmer, Héctor G.
  • Peeper, Daniel S.
  • Pelicci, Pier Giuseppe
  • Piris Gimenez, Alejandro
  • Roman Roman, Sergio
  • Rueda, Oscar M.
  • Seoane Suárez, Joan
  • Serra Elizalde, Violeta
  • Soucek, Laura
  • Vanhecke, Dominique
  • Villanueva Garatachea, Alberto
  • Vinolo, Emilie
  • Bertotti, Andrea
  • Trusolino, Livio
Patient-derived xenografts (PDXs) have emerged as an important platform to elucidate new treatments and biomarkers in oncology. PDX models are used to address clinically relevant questions, including the contribution of tumour heterogeneity to therapeutic responsiveness, the patterns of cancer evolutionary dynamics during tumour progression and under drug pressure, and the mechanisms of resistance to treatment. The ability of PDX models to predict clinical outcomes is being improved through mouse humanization strategies and the implementation of co-clinical trials, within which patients and PDXs reciprocally inform therapeutic decisions. This Opinion article discusses aspects of PDX modelling that are relevant to these questions and highlights the merits of shared PDX resources to advance cancer medicine from the perspective of EurOPDX, an international initiative devoted to PDX-based research.